Trazodone is not FDA approved for insomnia. The FDA has approved trazodone only for the treatment of major depressive disorder in adults. Despite this, trazodone is one of the most commonly prescribed medications for sleep problems in the United States, used off-label at low doses by millions of people every year.
This distinction matters because it means trazodone has never gone through the rigorous clinical trial process specifically required for an FDA sleep aid indication. The evidence supporting its use for insomnia is surprisingly thin compared to its popularity.
What “Off-Label” Means for Trazodone
Off-label prescribing is legal and common in medicine. It means a doctor prescribes a medication for a purpose other than its FDA-approved use. In trazodone’s case, drowsiness is a well-known side effect at antidepressant doses, and clinicians began prescribing it at much lower doses purely for that sedating property. Over time, this practice became so widespread that trazodone became the most prescribed off-label sleep medication in the country, even though no pharmaceutical company has pursued FDA approval for this specific use.
The FDA label for trazodone hydrochloride tablets states its indication plainly: “for the treatment of major depressive disorder (MDD) in adults.” There is no mention of insomnia or sleep disturbance as an approved use.
Why Trazodone Makes You Sleepy
At the doses used for sleep (far below antidepressant levels), trazodone’s sedation comes from blocking specific receptors in the brain. It blocks histamine receptors, the same system that older antihistamines like diphenhydramine target to cause drowsiness. It also blocks certain serotonin receptors involved in wakefulness and blocks receptors in the nervous system that regulate alertness and blood pressure.
These sleep-promoting effects kick in at low doses. The drug reaches peak levels in your blood about one hour after taking it on an empty stomach, or about two hours if you’ve eaten. Its initial half-life is roughly 3 to 6 hours, with a longer tail of 5 to 9 hours. This means it works relatively quickly for falling asleep, though some people find its effects linger into the morning.
Sleep Doses vs. Antidepressant Doses
The dosing gap between trazodone for sleep and trazodone for depression is substantial. For insomnia, doctors typically start at 25 to 50 mg at bedtime, with most people landing in the 50 to 100 mg range. The maximum sleep dose is generally around 200 mg.
For depression, the starting dose is 150 mg per day (split into multiple doses), and the therapeutic range is 200 to 400 mg daily, with a maximum of 600 mg for hospitalized patients. So the sleep dose is often one-quarter to one-sixth of what’s needed for antidepressant effects. At these lower doses, the sedating receptor activity dominates while the mood-related effects remain minimal.
What the Evidence Actually Shows
Here’s where things get complicated. Despite its enormous popularity as a sleep aid, the clinical evidence for trazodone’s effectiveness in insomnia is weak. A 2018 meta-analysis pooled seven randomized, placebo-controlled trials of trazodone for insomnia, covering nearly 4,300 patients total. The overall findings showed no improvements in sleep efficiency, sleep latency (how long it takes to fall asleep), or total sleep duration compared to placebo.
There was one modest bright spot: patients taking trazodone perceived better subjective sleep quality in three of the studies, meaning they felt like they slept better even though objective measurements didn’t confirm it. And even that finding was borderline, barely reaching statistical significance. The single study in that group that focused specifically on adults with primary insomnia (not insomnia caused by depression or another condition) found no significant benefit.
A head-to-head comparison also proved underwhelming. In a trial of 278 patients randomized to receive either zolpidem (the active ingredient in Ambien, an FDA-approved sleep drug), trazodone at 50 mg, or placebo, neither medication performed significantly better than placebo for sleep quality at the two-week mark. The placebo group’s sleep actually improved over time, catching up to the medication groups.
Why Doctors Still Prescribe It for Sleep
If the evidence is this limited, why do so many doctors prescribe trazodone for insomnia? Several practical reasons drive this pattern. FDA-approved sleep medications like zolpidem and eszopiclone carry risks of dependence, next-day impairment, and complex sleep behaviors like sleepwalking. Trazodone is not a controlled substance, has no significant abuse potential, and doesn’t carry the same dependency concerns. For doctors weighing risks, a medication with a mild side-effect profile and decades of clinical familiarity can feel like the safer choice, even with less robust efficacy data.
Trazodone is also inexpensive and available as a generic, making it accessible for patients without comprehensive insurance coverage. And many people with insomnia also have coexisting depression or anxiety, where trazodone’s dual action on mood and sleep can address both problems with a single prescription.
That said, the lack of FDA approval for insomnia isn’t just a bureaucratic detail. It reflects a genuine gap in evidence. The clinical trials that would be required for FDA approval, large-scale studies proving the drug works better than placebo for sleep over meaningful time periods, simply haven’t been done with results strong enough to support that indication. Many people report that trazodone helps them sleep, but controlled studies have struggled to confirm this beyond a placebo effect.
Side Effects at Sleep Doses
At the low doses used for sleep, trazodone is generally well tolerated, but side effects do occur. Morning grogginess is the most common complaint, partly because the drug’s half-life can extend effects into the next day. Dry mouth, dizziness, and lightheadedness (from its blood pressure-lowering properties) also occur. Some people experience headaches or nausea.
A rare but serious side effect called priapism, a prolonged and painful erection, has been reported in men taking trazodone. While uncommon, it requires emergency treatment and is worth knowing about. Weight gain is less of a concern with trazodone than with some other sedating antidepressants, which is another reason some clinicians favor it.